Craving
2 findings from 1 review
Secondary outcome: acceptability of treatment
1 finding from 1 review
Percentage days with substance use at
2 findings from 1 review
Consumed amount at post‐treatment Lower SMD favors MBI
1 finding from 1 review
Consumed amount at
1 finding from 1 review
Craving
1 finding from 1 review
Secondary outcome: acceptability of treatment
1 finding from 1 review
Adverse events · parents/children
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Frequency of alcohol misuse 6 months · Parents who use substances
1 finding from 1 review
Frequency of alcohol misuse 12 months · Parents who use substances
1 finding from 1 review
Frequency of drug use 12 months · Parents who use substances
2 findings from 1 review
Frequency of alcohol misuse 12 months · Parents who use substances
1 finding from 1 review
Frequency of drug use 12 months · Parents who use substances
2 findings from 1 review
Frequency of alcohol misuse 6 months · Parents who use substances
1 finding from 1 review
Extent of substance use at short‐term · people with substance use (adults, young adults, adolescents)
2 findings from 1 review
Extent of substance use at short‐term · people with substance use (adults, young adults, adolescents)
2 findings from 1 review
Retention in treatment · patients with treatment of opioid dependence
Any Psychosocial intervention plus pharm showed no clear difference in retention in treatment Objective compared with pharm standard (high certainty).
1 finding from 1 review
Opioid abstinence objective · patients with treatment of opioid dependence
Any Psychosocial intervention plus pharm showed no clear difference in opioid abstinence objective compared with pharm standard (high certainty).
1 finding from 1 review
Number of participants still in treatment at the end of · patients with treatment of opioid dependence
Any Psychosocial intervention plus pharm showed no clear difference in number of participants still in treatment at the end of compared with pharm standard (high certainty).
1 finding from 1 review
Abstinence · patients with treatment of opioid dependence
Any Psychosocial intervention plus pharm showed no clear difference in number of participants abstinent at the end of compared with pharm standard (high certainty).
1 finding from 1 review